Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

Han Yao^#¹, Jiang Lan^#², Chushu Li^#¹, Hubing Shi^#², Jean-Philippe Brosseau³, Huanbin Wang¹, Haojie Lu⁴, Caiyun Fang⁴, Yao Zhang¹, Lunxi Liang^{1

5}, Xiaolin Zhou⁶, Chaojun Wang⁷, Yu Xue⁸, Yun Cui¹, Jie Xu⁹

Affiliations

¹ State Key Laboratory for Oncogenes and Related Genes, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
² Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
³ Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
⁴ Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
⁵ Department of Gastroenterology, Changsha Central Hospital, Changsha, China.
⁶ Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
⁷ Urology Department, The First Affiliated Hospital of Zhejiang University, Zhejiang, China.
⁸ Department of Bioinformatics & Systems Biology, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
⁹ State Key Laboratory for Oncogenes and Related Genes, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. jiexu@yahoo.com.

^# Contributed equally.

PMID: 30976071
DOI: 10.1038/s41551-019-0402-7

Published Erratum

Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

Han Yao et al. Nat Biomed Eng. 2019 May.

. 2019 May;3(5):414.

doi: 10.1038/s41551-019-0402-7.

Authors

Affiliations

¹ State Key Laboratory for Oncogenes and Related Genes, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
² Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
³ Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
⁴ Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
⁵ Department of Gastroenterology, Changsha Central Hospital, Changsha, China.
⁶ Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
⁷ Urology Department, The First Affiliated Hospital of Zhejiang University, Zhejiang, China.
⁸ Department of Bioinformatics & Systems Biology, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
⁹ State Key Laboratory for Oncogenes and Related Genes, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. jiexu@yahoo.com.

^# Contributed equally.

PMID: 30976071
DOI: 10.1038/s41551-019-0402-7

Abstract

In the version of this Article originally published, 'palmitoyltransferase ZDHHC3 (DHHC3)' was incorrectly referred to as an 'acetyltransferase' rather than an as an 'acyltransferase'; this has now been corrected in five instances. In Fig. 3a, the label for the bottom row of the blots was mistakenly written as 'GAPHD'; it should have read 'GAPDH'. In the two right-most panels of Fig. 4j, the antibody labels 'α-PD-L1' for the reciprocal co-immunoprecipitation of DHHC3 were incorrect; they should have been 'α-DHHC3'. These errors have been corrected in all versions of the Article.

PubMed Disclaimer

Erratum for

Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours.
Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, Lu H, Fang C, Zhang Y, Liang L, Zhou X, Wang C, Xue Y, Cui Y, Xu J. Yao H, et al. Nat Biomed Eng. 2019 Apr;3(4):306-317. doi: 10.1038/s41551-019-0375-6. Epub 2019 Mar 25. Nat Biomed Eng. 2019. PMID: 30952982

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

Affiliations

Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials